by synergycap1 | Mar 14, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
The Congressional Budget Office has issued its report on the new Republican health care plan — and it’s bad news for the GOP. The nonpartisan CBO is considered the gold standard for judging the impact of new bills, even if it’s not perfect. Health...
by synergycap1 | Mar 14, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
An agreement to sell a stake in a New York skyscraper would be extremely lucrative for the family of Jared Kushner, and could protect the Chinese buyers from scrutiny.
by synergycap1 | Mar 14, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
A massive winter weather system has hit much of the Northeast as New York, New Jersey, Connecticut and Pennsylvania declare states of emergency. Winter storm Stella shut down schools and government offices, canceling thousands of flights and public transportation...
by synergycap1 | Mar 14, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
“The day that I ran my numbers and I was like, ‘Wow, whether or not I get out of bed today, my bills are paid,’ that was wealthy,” says Wrighster, speaking at the SXSW Festivals and Conferences in Austin, Texas, on Saturday. Even more than the...
by synergycap1 | Mar 14, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
LONDON (Reuters) – One of the biggest mysteries in global markets so far in the Trump era is the historically low level of volatility that has prevailed despite all the turmoil and uncertainty that analysts warned his victory would unleash.
by synergycap1 | Mar 14, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
NEW YORK (Reuters) – Drugmaker Valeant Pharmaceuticals will not see any changes to its planned refinancing in the wake of billionaire William Ackman and his hedge fund Pershing Square selling its share of the company, sources said.
